257 related articles for article (PubMed ID: 26006022)
1. Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.
Wei Q; Guo P; Mu K; Zhang Y; Zhao W; Huai W; Qiu Y; Li T; Ma X; Liu Y; Chen X; Han L
Lab Invest; 2015 Jul; 95(7):804-16. PubMed ID: 26006022
[TBL] [Abstract][Full Text] [Related]
2. E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells.
Wei Q; Zhu R; Zhu J; Zhao R; Li M
Oncol Res; 2019 Jul; 27(7):827-834. PubMed ID: 30940293
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment.
Awwad SF; Assaf RH; Emam AA; Fouad AA; Arafa LF; El-Hanafy AA
Med Oncol; 2023 Feb; 40(3):94. PubMed ID: 36763290
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression.
Wei Q; Mu K; Li T; Zhang Y; Yang Z; Jia X; Zhao W; Huai W; Guo P; Han L
Lab Invest; 2014 Jan; 94(1):52-62. PubMed ID: 24166187
[TBL] [Abstract][Full Text] [Related]
5. Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword.
Tang YL; Tao Y; Zhu L; Shen JL; Cheng H
Int Immunopharmacol; 2023 May; 118():110107. PubMed ID: 37028274
[TBL] [Abstract][Full Text] [Related]
6. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis.
Zhang Y; Yang H; Sun M; He T; Liu Y; Yang X; Shi X; Liu X
Pharmacol Rep; 2020 Oct; 72(5):1370-1382. PubMed ID: 32301055
[TBL] [Abstract][Full Text] [Related]
7. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
Li P; Liu Y; He Q
Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
[TBL] [Abstract][Full Text] [Related]
9. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
[TBL] [Abstract][Full Text] [Related]
10. Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Li MQ; Hu B; Zhang ZF; Cheng W; Shan Q
PLoS One; 2014; 9(2):e89961. PubMed ID: 24587153
[TBL] [Abstract][Full Text] [Related]
11. Estrogen ameliorates allergic airway inflammation by regulating activation of NLRP3 in mice.
Cheng C; Wu H; Wang M; Wang L; Zou H; Li S; Liu R
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30373775
[No Abstract] [Full Text] [Related]
12. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice.
Xu Y; Sheng H; Bao Q; Wang Y; Lu J; Ni X
Brain Behav Immun; 2016 Aug; 56():175-86. PubMed ID: 26928197
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.
Iyer JK; Kalra M; Kaul A; Payton ME; Kaul R
World J Gastroenterol; 2017 Oct; 23(37):6802-6816. PubMed ID: 29085224
[TBL] [Abstract][Full Text] [Related]
14. Activation of the NLRP3/IL-1β/MMP-9 pathway and intracranial aneurysm rupture associated with the depletion of ERα and Sirt1 in oophorectomized rats.
Yamaguchi T; Miyamoto T; Shikata E; Yamaguchi I; Shimada K; Yagi K; Tada Y; Korai M; Kitazato KT; Kanematsu Y; Takagi Y
J Neurosurg; 2023 Jan; 138(1):191-198. PubMed ID: 35594890
[TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
16. AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
Martínez-Cardona C; Lozano-Ruiz B; Bachiller V; Peiró G; Algaba-Chueca F; Gómez-Hurtado I; Such J; Zapater P; Francés R; González-Navajas JM
Int J Cancer; 2018 Dec; 143(11):2997-3007. PubMed ID: 30133699
[TBL] [Abstract][Full Text] [Related]
17. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
Saber S; Ghanim AMH; El-Ahwany E; El-Kader EMA
Cancer Chemother Pharmacol; 2020 Feb; 85(2):331-343. PubMed ID: 31989218
[TBL] [Abstract][Full Text] [Related]
18. Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells.
Dai B; Fan M; Huang X; Gong Z; Cao H; Hu Y; Su Q; Yang T; Chen Y; Peng X; Liu F; Zhang Y
Phytomedicine; 2022 Aug; 103():154249. PubMed ID: 35716538
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B.
Lee HH; Kim D; Jung J; Kang H; Cho H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502191
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17
Thakkar R; Wang R; Sareddy G; Wang J; Thiruvaiyaru D; Vadlamudi R; Zhang Q; Brann D
Oxid Med Cell Longev; 2016; 2016():8309031. PubMed ID: 27843532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
